Krystal Biotech, Inc. KRYS Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s common stock, shares, outstanding?
- Krystal Biotech, Inc. (KRYS) reported common stock, shares, outstanding of $29.44M in Q1 2026.
- How has Krystal Biotech, Inc.'s common stock, shares, outstanding changed year-over-year?
- Krystal Biotech, Inc.'s common stock, shares, outstanding increased by 1.9% year-over-year, from $28.9M to $29.44M.
- What is the long-term trend for Krystal Biotech, Inc.'s common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s common stock, shares, outstanding has grown at a 8.2% compound annual growth rate (CAGR), from $19.71M to $29.19M.